Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Adenovirus antibody (substance)

Known as: Adenovirus Ab, Adenovirus Antibody, Anti-Adenovirus Antibody 
An antibody produced by B-lymphocytes in response to adenovirus infection.
National Institutes of Health

Related topics

Related topics

10 relations
Adenovirus Ab:ACnc:Pt:Ser:QnAdenovirus Ab:Titr:Pt:Ser:QnAdenovirus Ab:Titr:Pt:Ser:Qn:Comp fixAdenovirus Antigen
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro.
In vivo regenerative gene therapy is a promising approach for bone regeneration and can help to address cell-source limitations… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
2007
2007
Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy.
Although replication-competent viruses have been developed to treat cancers, their cytotoxic effects are insufficient, as… 
Highly Cited
2004
Highly Cited
2004
Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice
Dendritic cells (DCs) are powerful antigen-presenting cells that process antigens and present peptide epitopes in the context of… 
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
2004
2004
Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants
The present study investigated a novel approach for gene therapy of heart valve disease and vascular disorders. We formulated and… 
2002
2002
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53
P53-based immunization is an attractive approach to cancer immunotherapy due to the accumulation of p53 protein in tumor, but not… 
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Highly Cited
2001
Highly Cited
2001
TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection
Tumor necrosis factor-α (TNF-α) is well recognized for its role in mediating innate immune responses. However, the mechanisms of… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2000
Highly Cited
2000
Targeting of adenoviral vectors through a bispecific single-chain antibody
Recombinant adenoviral vectors are attractive in the context of cancer gene therapy because they are capable of delivering genes… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2000
2000
Humoral immune responses to adenovirus vectors in the brain
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ gene introduced into the… 
1998
1998
Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.
Recent advances in molecular biology have made gene therapy for cancer feasible in clinical trials. Although recombinant… 
Highly Cited
1997
Highly Cited
1997
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial.
Ad CFTR, a replication-deficient adenovirus expressing the human cystic fibrosis transmembrane conductance regulator (CFTR), was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE